Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer’s disease and other dementias.
Florey researchers discover mRNA's Alzheimer's disease targeting potential.
Florey researchers discover mRNA's…
Florey researchers discover mRNA's Alzheimer's disease targeting potential.
Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer’s disease and other dementias.